Patents by Inventor Hafid Omar

Hafid Omar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9340588
    Abstract: Among the fewer than 10 proteins primarily secreted by the species Lactobacillus plantarum, there is one of 30 kDa that contains an internal fragment without cleavage sites for the most important intestinal proteases and characterized by having a serine and threonine content of at least 50%. The genetic information encoded in this fragment, designated ST peptide, has been used for producing and purifying the peptide, thus making it possible to conduct various tests in vitro. To summarize, the ST peptide is considered to promote the process of immunologic ignorance of our gastrointestinal immune system toward the commensal bacteria of our gastrointestinal tract, thus favoring the mechanisms of oral tolerance. Therefore the ST peptide could be used in immunotherapy, especially in the context of certain autoimmune diseases and certain inflammatory diseases.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: May 17, 2016
    Assignee: Imperial Innovations Limited
    Inventors: Borja Sanchez Garcia, Abelardo Margolles Barros, David Bernardo Ordiz, Stella C. Knight, Hafid Omar
  • Publication number: 20140296480
    Abstract: Among the fewer than 10 proteins primarily secreted by the species Lactobacillus plantarum, there is one of 30 kDa that contains an internal fragment without cleavage sites for the most important intestinal proteases and characterized by having a serine and threonine content of at least 50%. The genetic information encoded in this fragment, designated ST peptide, has been used for producing and purifying said peptide, thus making it possible to conduct various tests in vitro. To summarize, the ST peptide is considered to promote the process of immunologic ignorance of our gastrointestinal immune system toward the commensal bacteria of our gastrointestinal tract, thus favoring the mechanisms of oral tolerance. Therefore the ST peptide could be used in immunotherapy, especially in the context of certain autoimmune diseases and certain inflammatory diseases.
    Type: Application
    Filed: September 7, 2012
    Publication date: October 2, 2014
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Borja Sanchez Garcia, Abelardo Margolles Barros, David Bernardo Ordiz, Stella C. Knight, Hafid Omar